undamentalytics Newsletter
Sign in

Strata Critical Medical, Inc. cash flow statement

In fiscal 2025, Strata Critical Medical, Inc.'s operations generated −$48.9m of cash; it spent $9.6m on capital projects, leaving free cash flow of −$58.5m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Sept 20192020Sept 20202021Sept 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−10−11−16−37−32−3−49−36
Depreciation and amortisation01167689
Stock-based pay0010813201817
Capital spending10012311012
Free cash flow−11−11−16−38−34−33−59−48
Free cash flow after stock pay−11−12−26−46−47−53−76−65
Share buybacks————000—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: DLHC vs SRTADCGO vs SRTASRTA vs VMD

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Strata Critical Medical, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Strata Critical Medical, Inc.